EXCLUSIVE LICENSE AND SUPPLY AGREEMENT by and between PFIZER INC. and PROTALIX LTD. November 30, 2009Exclusive License and Supply Agreement • February 26th, 2010 • Protalix BioTherapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Exclusive License and Supply Agreement (this “Agreement”) dated as of November 30, 2009 between Protalix Ltd., a limited liability company incorporated under the laws of Israel with offices located at 2 Snunit Street, Science Park, P.O.B 455, Carmiel 20100, Israel (“Protalix”), and Pfizer Inc., a Delaware corporation with offices located at 235 East 42nd Street, New York, New York, 10017, U.S.A. (“Pfizer”).
